AI 폐 초음파 솔루션 시장 : 시장 예측(2026-2032년)

The AI Lung Ultrasound Solution Market is projected to grow by USD 2.99 billion at a CAGR of 8.80% by 2032.

AI Lung Ultrasound Solutions: Executive Overview

AI lung ultrasound solutions combine bedside ultrasound imaging with software that supports image acquisition, interpretation, documentation, and clinical workflow. Their relevance is increasing as healthcare systems seek radiation-free, portable approaches for evaluating pulmonary conditions across emergency, critical-care, respiratory, and point-of-care settings. Adoption depends on clinical validation, usability, interoperability, data governance, reimbursement, and the availability of trained users.

Clinical Workflow and Technology Shifts Reshaping Lung Ultrasound

The landscape is moving from standalone imaging toward integrated, workflow-oriented solutions. Portable and handheld ultrasound devices are enabling examinations closer to the patient, while automated guidance can assist users with probe positioning, image-quality assessment, and standardized scanning protocols. Increasing emphasis on longitudinal documentation, remote consultation, and integration with hospital information systems is also changing how lung ultrasound is performed and recorded. Successful implementation requires alignment among clinicians, technical teams, procurement leaders, and regulators.

How Artificial Intelligence Is Changing Lung Ultrasound Practice

Artificial intelligence can support lung ultrasound by identifying artifacts and patterns, flagging potentially abnormal findings, improving acquisition consistency, and helping clinicians structure reports. Its strongest practical contribution is decision support rather than replacement of clinical judgment. Performance may vary across devices, patient populations, operators, and clinical environments, making external validation and continuous monitoring essential. Leaders should prioritize explainability, calibrated alerts, cybersecurity, privacy protection, bias assessment, and clear accountability when AI-supported outputs influence care.

Regional Insights Across Six Healthcare Environments

North America is characterized by strong interest in point-of-care imaging, digitally enabled clinical workflows, and evidence-based integration into acute care. Europe places substantial emphasis on clinical governance, data protection, interoperability, and harmonized medical-device oversight. Asia-Pacific presents diverse adoption conditions, ranging from advanced hospital systems to settings where portability and workforce support are particularly important. Latin America may benefit from mobile, lower-complexity solutions that extend diagnostic capability beyond major urban facilities. Middle Eastern health systems are investing in digitally connected and specialized care environments, while Africa's opportunities are closely linked to affordability, rugged design, training, connectivity, and support for decentralized services.

Group-Level Signals Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN markets may value scalable solutions that accommodate uneven infrastructure, multilingual workflows, and varying levels of operator expertise. BRICS countries represent diverse healthcare systems in which local evidence, manufacturing capacity, affordability, and integration with public-sector services can shape adoption. The European Union places importance on regulatory compliance, privacy, interoperability, and clinical evidence across member states. G7 environments generally emphasize advanced validation, cybersecurity, workflow integration, and workforce productivity. GCC health systems may prioritize connected specialty care and centralized standards, whereas NATO-aligned healthcare environments may also consider resilience, portability, and continuity of diagnostic services in austere or disrupted settings.

Country-Level Priorities for AI Lung Ultrasound Solutions

Australia and Canada may focus on rural access, telehealth support, and integration across dispersed care networks. Brazil, Mexico, India, and South Africa can benefit from affordable, portable systems that address workforce and infrastructure variation. China, Japan, and South Korea are positioned to evaluate AI-enabled imaging alongside advanced hospital digitization, domestic technology ecosystems, and aging-population needs. France, Germany, Italy, Spain, and the United Kingdom are likely to emphasize regulatory alignment, clinical evidence, interoperability, and integration into established care pathways. The United States is likely to give particular attention to validation, liability, reimbursement, cybersecurity, and deployment across emergency, intensive-care, and outpatient settings. Russia's implementation considerations include infrastructure resilience, local capability, and access to validated technologies.

Practical Priorities for Industry Leaders

Industry leaders should first define specific clinical use cases and measurable outcomes, such as acquisition quality, reporting consistency, time to assessment, or escalation of care. They should build representative validation datasets, test performance across operators and devices, and publish evidence that clarifies where the solution is reliable and where human review is required. Interoperability with imaging archives and clinical records should be designed from the outset, alongside privacy controls, cybersecurity processes, and transparent model-governance policies. Training, change management, service support, and equitable access are as important as algorithmic performance. Partnerships with clinical institutions can help establish credible implementation pathways without obscuring responsibility for final clinical decisions.

Research Methodology for Assessing the Solution Landscape

This executive summary is based on a structured assessment of AI-enabled lung ultrasound as a clinical technology category. The approach considers application areas, workflow functions, enabling technologies, regulatory and reimbursement factors, infrastructure conditions, clinical evidence requirements, and adoption barriers. Regional, group, and country perspectives are developed through comparative analysis of healthcare-system maturity, point-of-care imaging needs, digital infrastructure, workforce conditions, and governance expectations. Findings are qualitative and directional; they do not represent market estimates, market sizing, market shares, or forecasts.

Conclusion: Building Safe, Useful, and Scalable Adoption

AI lung ultrasound solutions can strengthen portable pulmonary assessment when they are embedded in validated clinical workflows rather than deployed as isolated algorithms. The most durable progress will depend on reliable image acquisition, transparent decision support, interoperable records, strong governance, and practical training. Regional and national conditions will determine the pace and form of implementation, but the central requirement is consistent: technology must improve clinician capability, patient access, and care reliability while preserving human oversight.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. AI Lung Ultrasound Solution Market, by Component

• 7.1. Introduction
• 7.2. Hardware
  • 7.2.1. Handheld Devices
  • 7.2.2. Portable Systems
• 7.3. Services
  • 7.3.1. Installation Services
  • 7.3.2. Training And Support
    • 7.3.2.1. Onsite Training
    • 7.3.2.2. Remote Training
• 7.4. Software
  • 7.4.1. Analytics Software
  • 7.4.2. Imaging Software
  • 7.4.3. Integration Software

8. AI Lung Ultrasound Solution Market, by Technology

• 8.1. Introduction
• 8.2. Deep Learning
  • 8.2.1. Convolutional Neural Network
  • 8.2.2. Recurrent Neural Network
• 8.3. Machine Learning
  • 8.3.1. Random Forest
  • 8.3.2. Support Vector Machine

9. AI Lung Ultrasound Solution Market, by Imaging Mode

• 9.1. Introduction
• 9.2. B-Mode
• 9.3. Color Doppler
• 9.4. Elastography
• 9.5. M-Mode

10. AI Lung Ultrasound Solution Market, by Application

• 10.1. Introduction
• 10.2. Covid-19
• 10.3. Pleural Effusion
• 10.4. Pneumonia

11. AI Lung Ultrasound Solution Market, by End User

• 11.1. Introduction
• 11.2. Diagnostic Centers
  • 11.2.1. General Imaging Centers
  • 11.2.2. Specialist Centers
• 11.3. Home Care
• 11.4. Hospitals
  • 11.4.1. Private Hospitals
  • 11.4.2. Public Hospitals

12. AI Lung Ultrasound Solution Market, by Deployment Mode

• 12.1. Introduction
• 12.2. Cloud-Based
  • 12.2.1. Private Cloud
  • 12.2.2. Public Cloud
• 12.3. Hybrid
• 12.4. On-Premises

13. AI Lung Ultrasound Solution Market, by Region

• 13.1. Introduction
• 13.2. Asia-Pacific
• 13.3. North America
• 13.4. Latin America
• 13.5. Europe
• 13.6. Middle East
• 13.7. Africa

14. AI Lung Ultrasound Solution Market, by Group

• 14.1. Introduction
• 14.2. ASEAN
• 14.3. GCC
• 14.4. European Union
• 14.5. BRICS
• 14.6. G7
• 14.7. NATO

15. AI Lung Ultrasound Solution Market, by Country

• 15.1. Introduction
• 15.2. United States
• 15.3. Canada
• 15.4. Mexico
• 15.5. Brazil
• 15.6. United Kingdom
• 15.7. Germany
• 15.8. France
• 15.9. Russia
• 15.10. Italy
• 15.11. Spain
• 15.12. China
• 15.13. India
• 15.14. Japan
• 15.15. Australia
• 15.16. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2025
• 16.2. Market Concentration Analysis, 2025
  • 16.2.1. Concentration Ratio (CR)
  • 16.2.2. Herfindahl Hirschman Index (HHI)
• 16.3. Recent Developments & Impact Analysis, 2025
• 16.4. Product Portfolio Analysis, 2025
• 16.5. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Aidoc Ltd.
• 17.2. Butterfly Network, Inc.
• 17.3. Caption Health, Inc.
• 17.4. Deep Breathe Inc.
• 17.5. DiA Imaging Analysis Ltd.
• 17.6. Exo Imaging, Inc.
• 17.7. FUJIFILM Corporation
• 17.8. GE HealthCare Technologies, Inc.
• 17.9. Koninklijke Philips N.V.
• 17.10. Mindray Medical International Limited
• 17.11. Qure.ai Technologies Pvt. Ltd.
• 17.12. Samsung Electronics Co., Ltd.
• 17.13. Siemens Healthineers AG
• 17.14. ThinkSono Ltd.
• 17.15. Viz.ai, Inc.

18. Key Experts